Chen, Weiqi
Jiang, Lingling https://orcid.org/0000-0003-4694-6419
Duan, Chunling
Kang, Moorim
Ye, Jinyi
Wang, Ling
Pan, Yuesong https://orcid.org/0000-0003-3082-6789
Qu, Hui
Liao, Xiaoling
Zhou, Xuejiao
Li, Yichen
Gan, Zubao
Chen, Junnan
Schacht, Ian
Place, Robert F.
Li, Long-Cheng https://orcid.org/0000-0002-3971-6335
Wang, Yilong https://orcid.org/0000-0002-3267-0039
Article History
Received: 11 November 2025
Accepted: 28 May 2026
First Online: 15 July 2026
Ethics
Competing interests: L.-C.L., C.D., M.K., Y.L., Z.G., J.C., I.S. and R.F.P. were employed by Ractigen Therapeutics during the completion of this work. L.-C.L. and M.K. hold shares in Ractigen Therapeutics and are inventors on patents RAG-17 assigned to the company (as described in this study). The other authors declare no competing interests.